U.S. FDA Issues Complete Response Letter for Baricitinib
Go back to U.S. FDA Issues Complete Response Letter for Baricitinib| Incyte Genomics, Inc. (NASDAQ: INCY) | Delayed: 109.32 +1.49 (1.38%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $107.83 | 52 Week High | $118.49 | |||
| Open | $107.83 | 52 Week Low | $55.00 | |||
| Day High | $109.37 | P/E | N/A | |||
| Day Low | $106.53 | EPS | $-0.56 | |||
| Volume | 577,873 | |||||
| Lilly (Eli) & Co. (NYSE: LLY) | Delayed: 1144.39 -16.56 (1.43%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1160.95 | 52 Week High | $88.16 | |||
| Open | $1165.00 | 52 Week Low | $67.88 | |||
| Day High | $1169.99 | P/E | 264.91 | |||
| Day Low | $1142.51 | EPS | $4.32 | |||
| Volume | 1,041,637 | |||||
